Los puntos clave no están disponibles para este artículo en este momento.
Although EGFR mutation prevalence was higher in Asian than Western countries, data support worldwide testing for EGFR overall and submutations to inform appropriate targeted treatment decisions.
Melosky et al. (Tue,) studied this question.